Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stravix for Erectile Recovery After Radical Prostatectomy
NCT05366842Phase 2Terminated
- Sponsor
- Johns Hopkins University
- Start
- Apr 2022
- Primary completion
- Apr 2025
- Modality
- Tissue Cells
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in erectile dysfunction (ED) and urinary incontinence (UI) comparing Stravix with Standard of Care (2 arms). Primary endpoints: International Index of Erectile Function at 18 months, Mean time to achieve potency up to 1 year and 2 more. Started Apr 2022; status: terminated.
02
Drugs
Stravix
03
Conditions
erectile dysfunction (ED)urinary incontinence (UI)
Beyond the preview
Go deeper on NCT05366842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05366842.